why choose us

300×250 Ad Slot

Research Article: BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression

Date Published: 2024-12-09

Abstract:
Introduction: BRAFV600E mutation (BRAFmut) is common in papillary thyroid cancer (PTC), and most patients have an excellent outcome. However, a TERT-promoter mutation (pTERTmut) in the presence of BRAFmut (BRAFmutpTERTmut) has been demonstrated to confer a more aggressive behavior to PTC. Lymphocytic infiltration is often present in PTC. In this study, we sought to decipher the relationship between the BRAF and pTERT mutations and immune gene dysregulation in tumor samples from a cohort of 147 samples of PTC.

No summary available.

300×250 Ad Slot